Spanish Group for Cancer Immuno-Biotherapies 12th Forum on Translational Immunology and Immunotherapy of Cancer 2026

Organized by the Spanish Group for Cancer Immuno-Biotherapies (GÉTICA), the 12th Forum on Translational Immunology and Immunotherapy of Cancer (FIT Cancer 12) is a benchmark scientific and educational event in the field. The forum will take place in Málaga, Spain, from March 5 to 6, 2026, at the Hotel ILUNION Málaga. The event aims to bridge the gap between basic immunology research and clinical oncology by presenting the latest advancements in cancer immunotherapy and multimodal treatments.
Learning Objectives

Understand the fundamental principles of tumor immunology, detailing both innate and adaptive immune responses, as well as antigen presentation.

Analyze the critical role of cytokines and the tumor microenvironment in cancer progression and therapy.

Evaluate the foundational principles and clinical potentials of modern cell therapies and radioimmunobiology.

Navigate complex clinical decision-making, specifically regarding immunotherapy rechallenge after patients experience grade 3 immune-mediated toxicities.

Assess the latest clinical advances, emerging biomarkers, and integration strategies for radio-immunotherapy across specific malignancies, including gastrointestinal, bladder, gynecological, and head and neck cancers.

Target Audience
This forum is designed for medical oncologists, immunologists, radiation oncologists, clinical researchers, translational scientists, and physicians-in-training (such as MIR residents) who are deeply involved in the research, development, and clinical application of cancer immunotherapies.
Best for Medical Oncologists, Radiation Oncologists, Immunologists, Urologists, Gynecologic Oncologists, and Gastroenterologists.
Topics
Educational Session I: Principles of Tumor Immunology and Immunotherapy

Innate immune response

Adaptive immune response and antigen presentation

Cytokines and the tumor microenvironment

Principles of cell therapy

Introduction to radioimmunobiology

Educational Session II: Applying Concepts Through Clinical Cases (GÉTICA–SEOM + MIR Session)

Rechallenge with immunotherapy after grade 3 immune-mediated toxicity: clinical experience and case discussions

Scientific Symposium GÉTICA – Session 1: Radio-Immunotherapy

Oligoprogression in the immunotherapy era: turning radiotherapy into a partner

Epigenetics meets radio-immunotherapy: biomarkers and future directions

Integrating radiotherapy and immune modulation: emerging strategies and translational perspectives in head and neck cancer

Scientific Symposium GÉTICA – Session 2: Immunotherapy Advances with Clinical Focus

What is new in bladder cancer?

What is new in gynecological cancer?

What is new in gastrointestinal cancer?

Core Thematic Areas for Research and Communications

Cell therapies

New immunotherapy strategies for cancer treatment

Biomarkers of response or toxicity to immunotherapy

Integration of immunotherapies into multimodal treatments

Mechanisms of response/resistance to immunotherapy